Keystonemab
Keystonemab is a pharmaceutical AI platform that leverages big data analytics from millions of scientific articles, patents, and public data banks to provide actionable insights for drug development. Their mission is to change the paradigm in pharma by using AI-supported predictive analysis for synergistic drug combinations and multi-API formulations. Keystonemab specializes in identifying synergistic drug combinations, drug repositioning for indication expansion, discovering novel druggable targets, commercial product portfolio analysis, and multi-API oral drug formulation. Their platform supports biopharmaceutical companies, academic institutions, and venture capitalists by organizing scientific data, identifying research trends, and providing market intelligence for deal evaluation. They offer services on a fee-for-service basis, through partnerships with shared benefits, or by building an internal pipeline for drug development and eventual M&A.
Keystonemab
Keystonemab is a pharmaceutical AI platform that leverages big data analytics from millions of scientific articles, patents, and public data banks to provide actionable insights for drug development. Their mission is to change the paradigm in pharma by using AI-supported predictive analysis for synergistic drug combinations and multi-API formulations. Keystonemab specializes in identifying synergistic drug combinations, drug repositioning for indication expansion, discovering novel druggable targets, commercial product portfolio analysis, and multi-API oral drug formulation. Their platform supports biopharmaceutical companies, academic institutions, and venture capitalists by organizing scientific data, identifying research trends, and providing market intelligence for deal evaluation. They offer services on a fee-for-service basis, through partnerships with shared benefits, or by building an internal pipeline for drug development and eventual M&A.